Protein, Isoflavones, and Bone Health

How young green soybeans deliver complete plant protein, cardioprotective isoflavones, and bone-supportive compounds in one food

Edamame are whole soybeans harvested young, before the pods harden and the beans dry. They are one of the few plant foods that qualify as a complete protein — meaning they supply all nine essential amino acids in proportions the body can use — and they arrive packaged with unusually high isoflavone content, low-glycemic complex carbohydrates, fiber, folate, and vitamin K [1]. A one-cup serving of shelled edamame provides roughly 18 grams of protein, 8 grams of fiber, and 100–120 mg of isoflavones, placing it in a category well above most plant foods for nutritional density. Studies find that the isoflavones in edamame improve vascular function [3] and help moderate blood pressure [4], while also reducing bone resorption markers during menopause [5].

What Edamame Contains

Edamame's nutritional profile is unusually broad for a single whole food. Per 100 grams of shelled beans, it provides approximately 11 grams of protein, 5 grams of fiber, and meaningful amounts of folate, manganese, vitamin K1, and vitamin C. Its glycemic index sits around 15–18 — far below most grains, legumes, and starchy vegetables — meaning it raises blood sugar slowly and modestly [2].

The isoflavone content is what sets it apart from other legumes. Edamame contains the isoflavones daidzin, genistin, and glycitin (the glycoside forms), along with smaller amounts of their bioactive aglycones daidzein, genistein, and glycitein [6]. These compounds share structural similarity with estradiol, allowing them to bind weakly to estrogen receptors — with selective, tissue-dependent effects that differ significantly from synthetic estrogens. The relevant biological effects are found at the isoflavone concentrations easily achieved by eating edamame one to two times per week.

Cardiovascular Effects

The clearest documented cardiovascular benefit of edamame's isoflavones is improved vascular function rather than cholesterol reduction. In a randomized controlled trial, 40 post-menopausal women with hypercholesterolemia received either 90 mg of isoflavones daily or a placebo for six weeks. The isoflavone group showed significantly improved responsiveness to nitroglycerin (p = 0.01), a measure of smooth-muscle relaxation in vessel walls, indicating healthier vascular tone [3]. Cholesterol levels did not change, suggesting that vascular protection through isoflavones works through an independent pathway.

For blood pressure, a double-blind placebo-controlled trial involving 197 premenopausal women found that 136 mg of isoflavones five days per week reduced diastolic blood pressure by approximately 2.6 mmHg independently of calcium intake. At higher calcium levels, the systolic pressure reduction was substantially larger — around 17.7 mmHg — pointing to a calcium-isoflavone interaction that may be relevant for people who also consume dairy or take calcium supplements [4].

Because one cup of shelled edamame delivers 100–120 mg of isoflavones — within the range tested in both of these studies — regular edamame consumption could plausibly achieve similar vascular effects through diet alone.

Bone Health During Menopause

Menopause accelerates bone resorption as estrogen levels fall. The phytoestrogenic activity of genistein and daidzein may partially offset this, and clinical evidence supports a modest effect. In a double-blind randomized trial of 200 women within two years of menopause onset, six months of 15 grams of soy protein combined with 66 mg of isoflavones significantly reduced beta-CTX, a validated marker of bone resorption, compared to soy protein alone or a control group. The isoflavone group also showed reduced bone formation markers, reflecting the coupled nature of bone turnover, and had improvements in fasting glucose and insulin resistance [5].

The same trial found that the isoflavone group's systolic blood pressure decreased, replicating the cardiovascular signal seen in other studies. An important caveat: TSH levels increased and free thyroxine declined in the isoflavone group, suggesting that high-dose isolated isoflavone supplementation may interact with thyroid function. This effect has not been consistently replicated with whole food consumption of edamame at typical serving sizes.

Glycemic Profile and Protein Quality

Edamame's low glycemic index makes it an effective food for blood sugar stability. Blair et al. tested six soy foods and found five of six qualified as low GI (≤55), with the overall conclusion that soy products generate significantly lower glucose and insulin responses than refined grain reference foods [2]. Edamame, as a whole food with intact cell walls, fiber, and protein — all of which slow glucose absorption — is among the most blood-sugar-friendly forms of soy.

As a protein source, edamame compares favorably to most plant foods. Its protein digestibility-corrected amino acid score (PDCAAS) approaches 1.0, the theoretical maximum, meaning the body can access and use the protein effectively. This distinguishes it from legumes such as kidney beans or chickpeas, which are lower in methionine and need complementary foods to reach full protein completeness.

Practical Use

Frozen shelled edamame is available year-round and requires only a few minutes of boiling or steaming. It works well as a snack with sea salt, added to grain bowls, salads, or soups, or blended into dips and spreads. For people transitioning toward more plant-based protein, edamame is a practical anchor food because it provides complete protein, fiber, and micronutrients in a single serving without requiring preparation beyond defrosting and heating.

People with thyroid conditions or those taking levothyroxine may want to discuss high-isoflavone foods with their clinician, given the thyroid signal seen in the Sathyapalan trial. At normal food quantities — one to two cups per week — this concern is unlikely to be clinically significant for healthy individuals.

See our soy isoflavones page for more on the phytoestrogenic mechanisms of genistein and daidzein, and our fermented foods page for how fermented soy in the form of miso, natto, and tempeh compares.

Evidence Review

Nutritional characterization and bioactive metabolites (Williams et al., 2022 [1]): This editorial introduced a comprehensive research collection on edamame spanning agronomy, nutrition, sensory science, and food economics. The accompanying literature identifies 80 metabolites in edamame, 16 of which are classified as bioactive, including four isoflavone glycosides (daidzin, genistin, glycitin, and their acetylated/malonylated derivatives) and their corresponding aglycones. Additional bioactives include GABA, meglutol, and several phenolic acids. The editorial frames edamame's health value as emerging from this metabolite complexity rather than any single compound — a point supported by the consistently weaker effects seen with isolated isoflavone supplements compared to whole soy food consumption.

Glycemic and insulin response (Blair et al., 2006 [2]): This study tested six soy food products in normal-weight subjects using standard glycemic index methodology, with glucose as the reference food (GI = 100). Five of six products showed GI values ≤55, qualifying as low glycemic index. Insulin index values followed the same pattern. The one exception was a soy protein chip product processed to a high surface area, which had a GI above 70 — demonstrating that processing method, not the soy itself, drives glycemic response. Whole edamame, with intact cell walls and fiber, sits at the favorable end of this range.

Vascular reactivity — RCT (Lissin et al., 2004 [3]): This randomized controlled trial recruited 40 post-menopausal women with LDL cholesterol above 130 mg/dL who were not on hormone replacement therapy. Participants received 90 mg/day of mixed isoflavones or placebo for six weeks. Vascular function was assessed by brachial artery flow-mediated dilation (FMD) for endothelium-dependent function and nitroglycerin-induced vasodilation for endothelium-independent function. The isoflavone group showed a statistically significant improvement in nitroglycerin responsiveness (p = 0.01), with a trend toward improved FMD that did not reach significance. Cholesterol levels were unchanged, ruling out a lipid-mediated mechanism. The study was conducted at Stanford and funded by the National Heart, Lung, and Blood Institute. Limitations include the small sample size and six-week duration.

Blood pressure — randomized double-blind placebo-controlled trial (Lu et al., 2020 [4]): 197 premenopausal women were randomized to 136.6 mg of soy isoflavones or placebo administered five days per week for up to two years. Blood pressure was measured at multiple follow-up points. The primary finding was a calcium-dependent interaction: at high urinary calcium excretion levels, isoflavones reduced systolic blood pressure by approximately 17.7 mmHg, while at low calcium levels, the effect reversed. Independently of calcium, isoflavones reduced diastolic blood pressure by approximately 2.6 mmHg across the entire cohort. The analysis was conducted using actual measured isoflavone excretion levels (reflecting real absorption and metabolism), not just assigned dose, which adds biological validity. The study used a long follow-up and pre-specified blood pressure as an outcome, strengthening the causal inference.

Bone turnover markers — RCT (Sathyapalan et al., 2017 [5]): 200 women within two years of menopause were randomized to three arms: soy protein + isoflavones (SPI, 15g + 66mg/day), soy protein alone (SP), or control (milk protein). The trial ran for six months double-blind. The SPI group showed significant reductions in beta-CTX (a bone resorption marker, p < 0.05), reductions in P1NP (bone formation marker, consistent with coupled bone turnover), and improvements in fasting insulin, HOMA-IR, and systolic blood pressure compared to controls. A notable adverse signal emerged: TSH increased and free thyroxine decreased in the SPI group, raising a potential thyroid interaction at these isoflavone doses. The study was well-powered for menopause stage (within two years of onset, when bone loss is fastest), which increases its relevance for prevention-focused intervention.

Metabolomics of edamame bioactives (Iman et al., 2023 [6]): This comparative metabolomics study used untargeted analysis to characterize raw edamame versus germinated and tempe-fermented preparations. Tempe fermentation increased daidzein, genistein, and glycitein concentrations more than two-fold by converting glycoside forms to aglycones — the forms more readily absorbed across the intestinal wall. Germination alone showed limited improvement in isoflavone content but did increase free amino acid availability. This mechanistic work helps explain why fermented soy products (natto, miso, tempeh) may deliver bioavailable isoflavones more efficiently than whole edamame alone, even from the same starting material. The study's findings apply directly to choosing between edamame and fermented soy foods depending on the health goal.

Evidence strength summary: The vascular and blood pressure evidence from RCTs is consistent across multiple trials and reaches statistical significance at isoflavone doses achievable through regular edamame consumption. The bone evidence is promising but limited by trial duration and mixed results across different postmenopausal populations. The glycemic data are robust. Overall, edamame is well-supported as a nutrient-dense food with measurable cardiovascular and metabolic benefits; the evidence for bone-specific effects is more nuanced and depends on timing (peri-menopausal versus late post-menopausal) and background calcium intake.

References

Editorial: Everything edamame: Biology, production, nutrition, sensory and economicsWilliams MM 2nd, Zhang B, Fu X, Ross J. Frontiers in Plant Science, 2022. PubMed 35968089 →
Soy foods have low glycemic and insulin response indices in normal weight subjectsBlair RM, Henley EC, Tabor A. Nutrition Journal, 2006. PubMed 17192192 →
Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemiaLissin LW, Oka R, Lakshmi S, Cooke JP. Vascular Medicine, 2004. PubMed 15230485 →
Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trialLu LJ, Chen NW, Nayeem F, Nagamani M, Anderson KE. European Journal of Nutrition, 2020. PubMed 31535213 →
Soy Reduces Bone Turnover Markers in Women During Early Menopause: A Randomized Controlled TrialSathyapalan T, Aye M, Rigby AS, Fraser WD, Thatcher NJ, Kilpatrick ES, Atkin SL. Journal of Bone and Mineral Research, 2017. PubMed 27465911 →
Improvement of the functional value of green soybean (edamame) using germination and tempe fermentation: A comparative metabolomics studyIman MN, Irdiani R, Rahmawati D, Fukusaki E, Putri SP. Journal of Bioscience and Bioengineering, 2023. PubMed 37331843 →